论文部分内容阅读
目的:总结新活素(重组人脑利钠肽,rhBNP)治疗心力衰竭的临床应用及护理经验。方法:在PubMed和中国期刊全文数据库检索关于应用新活素治疗心力衰竭及患者护理的文献资料,结合文献计量分析和笔者日常实际工作中的体会和经验。结果:经过新活素合理用药和护理,通过利尿、降压、增强左心室射血分数和修复心脏功能等药理作用,心力衰竭临床症状可以得到及时减轻和控制,但其长期效果仍有待进一步研究。结论:新活素治疗各种心力衰竭临床疗效显著,不良反应发生率低,针对性的护理干预对提高疗效和患者的生活质量有重要作用。
Objective: To summarize the clinical application and nursing experience of new activin (recombinant human brain natriuretic peptide, rhBNP) in the treatment of heart failure. Methods: We searched the PubMed and Chinese Journal Full-text Database for literature about the treatment of heart failure and patient care by using new Survivin, combined with the literature analysis and the experience and experience of the author in daily practical work. Results: The clinical symptoms and signs of heart failure could be alleviated and controlled in time through the rational use of new Survivin and nursing, and the pharmacological effects such as diuretic, antihypertensive, enhancing left ventricular ejection fraction, and repairing cardiac function. However, its long-term effect remains to be further studied . Conclusion: The new survivin treatment of various clinical manifestations of heart failure was significant, the incidence of adverse reactions is low, targeted nursing intervention to improve the efficacy and quality of life of patients has an important role.